Helium Evolution Enters Into Investor Relations Agreement and Amends Option Agreement

Helium Evolution signs $15,000/month IR deal and extends 200,000 consultant options.

What the company is saying

Helium Evolution Incorporated (TSXV:HEVI, OTCQB:HEEVF) has entered into an investor relations agreement with Alliance Advisors Canada Corp. d/b/a Alliance Advisors IR, effective November 4, 2026. The company frames this as a step to enhance shareholder and investment community engagement, emphasizing Alliance's role in investor relations, strategic communications, media, and marketing. The agreement is for six months, then continues month-to-month, with a $15,000 monthly fee billed quarterly in advance during the initial term and monthly thereafter, plus reimbursement for pre-approved expenses. The company highlights that Alliance and its insiders are arm's length and have no securities interest or rights to acquire any. No securities will be issued as compensation for the services. Separately, the board approved amending 200,000 vested incentive stock options, originally granted to a consultant at $0.20 per share on October 29, 2025, by extending their expiry to October 29, 2027, with no other changes. The company states that none of these options are held by insiders. Both the IR agreement and the option amendments require TSX Venture Exchange approval.

What the data suggests

The IR agreement commits Helium Evolution to a fixed monthly cost of $15,000, billed quarterly in advance for the first six months, with additional reimbursement for pre-approved expenses, establishing a clear cash outflow for investor relations and marketing. No equity or options are being granted to Alliance Advisors IR, limiting dilution risk. The contract is initially six months, after which it becomes month-to-month, providing flexibility. The amendment to 200,000 consultant options extends their expiry by two years to October 29, 2027, at an unchanged exercise price of $0.20 per share, with all options already vested and none held by insiders. Both actions are subject to TSXV approval, so neither is yet effective. The announcement does not disclose any operational, financial performance, or project milestones, and there is no evidence provided for the anticipated benefits of the IR engagement. All figures and terms are clearly stated, but the impact on company performance or shareholder value is not quantifiable from the disclosed facts.

Analysis

The announcement is administrative, covering an investor relations agreement and an amendment to consultant stock options. All disclosed facts—such as the IR contract's term, fee, and the amended option expiry—are specific and factual, with no exaggerated claims about operational or financial performance. While there are some forward-looking statements (anticipated benefits of the IR engagement, TSXV approval), these are routine and not promotional. No operational milestones, revenue, or profitability metrics are discussed, nor are there claims of imminent business transformation or financial impact. The language is proportionate to the content, and there is no attempt to inflate the significance of these routine corporate actions. The only capital outlay is the IR fee, which is modest and not paired with any claims of transformative returns.

Risk flags

• ●The $15,000 monthly IR fee, plus reimbursable expenses, represents a recurring cash outflow that may not yield measurable returns if the investor relations efforts do not translate into increased investor interest or capital access. The absence of performance metrics or deliverables tied to the IR contract increases the risk that the expenditure could be sunk cost.
• ●Both the IR agreement and the option amendments are subject to TSXV approval, introducing regulatory risk. If approval is delayed or not granted, the agreements cannot be implemented as described, which could disrupt planned communications or consultant incentive structures.
• ●The extension of 200,000 vested consultant options at $0.20 per share to October 29, 2027, could result in future dilution if exercised, though the options are not held by insiders. The lack of disclosure about the consultant's identity or rationale for the extension leaves open questions about alignment and necessity.

Bottom line

This announcement is administrative, detailing a $15,000 per month investor relations contract with Alliance Advisors IR and a two-year expiry extension for 200,000 vested consultant stock options at $0.20 per share. No securities are being issued to Alliance, and both the IR contract and option amendment require TSXV approval before taking effect. The company provides full transparency on contract terms and option details, but there is no evidence or guidance on how these actions will impact operations, financials, or shareholder value. The recurring IR fee is a clear cost, and the option extension may lead to future dilution, but neither move signals a change in business fundamentals. Investors should recognize these as routine corporate actions with limited immediate impact; the most material next step is TSXV approval.

Announcement summary

(TSXV:HEVI, OTCQB:HEEVF) Helium Evolution Incorporated announced that it has entered into an investor relations agreement with Alliance Advisors Canada Corp. d/b/a Alliance Advisors IR, effective November 4, 2026. Under the IR Agreement, Alliance will provide investor relations, strategic communications, media relations, and marketing services, including news release development, investor conference participation, social media management, and other outreach activities. The IR Agreement has a six-month initial term starting November 4, 2026, after which it continues month-to-month unless terminated by either party with 30 days’ written notice. Helium Evolution will pay Alliance a monthly fee of $15,000, billed quarterly in advance during the initial term and monthly thereafter, plus reimbursement for pre-approved expenses. Alliance and its insiders are arm's length to Helium Evolution, have no direct or indirect interest in the company or its securities, and will not receive any securities as compensation for their services. The company also announced that its Board of Directors has approved the amendment of 200,000 incentive stock options previously granted to a consultant under its stock option plan. These Amended Options, all of which have vested, were originally granted on October 29, 2025, at an exercise price of $0.20 per share. The expiry date of the Amended Options has been extended to October 29, 2027, with no other changes to the terms. None of the Amended Options are held by insiders of the company. Both the IR Agreement and the Option Amendments are subject to TSX Venture Exchange approval.

Disagree with this article?